Honorary Consultant in Medical Oncology – Al Amal Hospital, Doha
Professor of Cancer Medicine,
Nuffield Dept of Clinical and Laboratory Sciences, 2010 - present
Seconded as Health Adviser to Sec State for Health ,UK October, 2010 – August, 2012
Adjunct Professor of Medicine, Weill Cornell Medical College, 2009 - present
President, European Soc Medical Oncology, 2009 – 11
Chief Medical officer, Oxford Cancer Biomarkers, 2011 - present
Central Committee for Estates (representing Division of Medicine), 2006-2009
National
Medical Research Council, Molecular and Cell Medicine Board, Committee A, Member (1993-1997)
Medical Research Council, Colorectal Cancer Working Party, Member - responsible for co-ordinating two international trials in advanced colorectal cancer. (1992-2003)
Medical Research Council, Clinical Fellowships Panel. (1993-1996)
Medical Research Council, Realising Our Potential Awards Committee.(1995-1996)
Medical Research Council, LINK with Industry Panel. (1995)
Advisory Group to Commission for Health Improvement (1998)
Cancer Research Campaign, Clinical Trials Committee, Member (1998-2001)
Chairman, National Cancer services Collaborative (budget £30 million). (1999 – 2003)
Chairman and Clinical Lead, Department of Health Audit on Cancer Waiting Times. (1999)
Founding Commissioner, Commission for Health Improvement.(1999-2001)
Cancer Research Campaign, Site Visit Committee member and responsibility for grant reports.
Adviser, Commonwealth Scholarships and Fellowships (1999 – present)
National Cancer Task Force, Member. (2000 – 9)
Director of National Translational Cancer Research Network (2001- 2006)
Chairman National Cancer Research Institute’s adjuvant colorectal cancer trials group (2003 – 8)
Member, National Colorectal Cancer Advisory Group (2003 – present)
Member, Department of Health Research for Patient Benefits Working Party (2003- 2005)
Chairman, National Framework for NHS in Scotland: Advisory Group (2004 – 2005)
